ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/04/2024
Back to search
Official data from USPTO
THE RNA PRINTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE RNA PRINTER
ST13
US500000097229623Class
1, 5, 9, 42, 44
Filing
97229623
Registration
7289725
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
12/04/2024
Trademark type
Word
Nice classes
1, 5, 9, 42, 44
Filing date
01/20/2022
Registration date
01/23/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/23/2024
Last transaction
02/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Foreign priority
Drawing code
4
Owner type
27
Owner location
T�BINGEN, DE
Examiner
DUBOIS, SUSAN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CUREVAC MANUFACTURING GMBH
CureVac RNA Printer GmbH
Representatives
Jennifer Fraser DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 1Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
(Based on 44(e)) Chemicals and biomoleculesin particular biological macromoleculesfor industrial or scientific purposes; Reagents for research purposes
Class 5
(Based on 44(e)) Chemical preparations for medical usefor therapeutic and prophylactic treatment of neurologicalneuromuscularneurodegenerativeinfectious and cardiovacular diseasesof autoimmune diseases and tumoursof allergiesof metabolic diseasesof heritable genetic diseasesfor therapies replacing proteins or enzymes; Pharmaceutical and veterinary preparations; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor treatment of infectious diseasesallergiesautoimmune disorder and tumour diseasesfor treatment of metabolic disorders and for treatment of inherited genetic disease or for protein or enzyme replacement therapy; Gene therapeutic preparationsnucleic acid macromolecules for in vivo expression for human or veterinary medical use; Health care productsbacterioligicalbacterialvitaminsanitary preparations for medical use; Dietetic substances adapted for medical usein particular substances for food supplements
Class 9
(Based on 44(d) Priority Application) Apparatus for chemical synthesis; mobile laboratory; mobile device for the synthesis of macromolecules
Class 42
(Based on 44(e)) Scientific and technological services and researchin particular for identificationtesting and characterisation of biological molecules; pre-clinical and clinical scientific testing of macromolecules
Class 44
(Based on 44(e)) Medical and veterinary servicesin particular for therapeutic and preventative treatment of tumour diseasesinfectious diseasesautoimmune disorders and allergiesfor treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor treatment of metabolic disorders
Publications
History of USPTO decisions and trademark events.
14 publications found
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/23/2024
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/23/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10/18/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/27/2023
ALIE
ASSIGNED TO LIE
09/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/08/2022
GNRT
NON-FINAL ACTION E-MAILED
11/08/2022
CNRT
NON-FINAL ACTION WRITTEN
11/08/2022
DOCK
ASSIGNED TO EXAMINER
10/30/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/25/2022
NWAP
NEW APPLICATION ENTERED
01/24/2022
Continuous trademark protection
Get notified about every new filing that threatens THE RNA PRINTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.